Baolingbao Biology Co Ltd
SZSE:002286
Income Statement
Earnings Waterfall
Baolingbao Biology Co Ltd
Revenue
|
2.5B
CNY
|
Cost of Revenue
|
-2.3B
CNY
|
Gross Profit
|
197.5m
CNY
|
Operating Expenses
|
-119.8m
CNY
|
Operating Income
|
77.8m
CNY
|
Other Expenses
|
-23.8m
CNY
|
Net Income
|
54m
CNY
|
Income Statement
Baolingbao Biology Co Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
901
N/A
|
901
+0%
|
963
+7%
|
941
-2%
|
911
-3%
|
992
+9%
|
1 078
+9%
|
1 155
+7%
|
1 196
+4%
|
1 175
-2%
|
1 200
+2%
|
1 271
+6%
|
1 377
+8%
|
1 477
+7%
|
1 553
+5%
|
1 583
+2%
|
1 593
+1%
|
1 605
+1%
|
1 615
+1%
|
1 649
+2%
|
1 730
+5%
|
1 740
+1%
|
1 778
+2%
|
1 785
+0%
|
1 805
+1%
|
1 810
+0%
|
1 955
+8%
|
2 038
+4%
|
2 055
+1%
|
2 209
+7%
|
2 300
+4%
|
2 589
+13%
|
2 765
+7%
|
2 868
+4%
|
2 886
+1%
|
2 769
-4%
|
2 713
-2%
|
2 665
-2%
|
2 612
-2%
|
2 597
-1%
|
2 524
-3%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(769)
|
(781)
|
(842)
|
(836)
|
(803)
|
(877)
|
(947)
|
(1 013)
|
(1 034)
|
(1 008)
|
(1 029)
|
(1 081)
|
(1 175)
|
(1 280)
|
(1 354)
|
(1 393)
|
(1 380)
|
(1 407)
|
(1 417)
|
(1 442)
|
(1 489)
|
(1 509)
|
(1 533)
|
(1 533)
|
(1 539)
|
(1 573)
|
(1 719)
|
(1 830)
|
(1 868)
|
(2 036)
|
(2 100)
|
(2 286)
|
(2 397)
|
(2 469)
|
(2 499)
|
(2 458)
|
(2 404)
|
(2 390)
|
(2 374)
|
(2 351)
|
(2 326)
|
|
Gross Profit |
132
N/A
|
120
-9%
|
121
+1%
|
106
-13%
|
107
+2%
|
115
+7%
|
130
+13%
|
142
+9%
|
163
+14%
|
167
+3%
|
171
+2%
|
190
+11%
|
202
+6%
|
197
-3%
|
199
+1%
|
190
-5%
|
213
+12%
|
197
-7%
|
198
+0%
|
207
+5%
|
241
+16%
|
231
-4%
|
245
+6%
|
252
+3%
|
267
+6%
|
237
-11%
|
236
-1%
|
208
-12%
|
187
-10%
|
172
-8%
|
200
+16%
|
303
+52%
|
368
+21%
|
399
+8%
|
388
-3%
|
311
-20%
|
308
-1%
|
276
-11%
|
238
-14%
|
246
+4%
|
198
-20%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(106)
|
(103)
|
(108)
|
(106)
|
(112)
|
(113)
|
(125)
|
(133)
|
(140)
|
(144)
|
(147)
|
(161)
|
(166)
|
(157)
|
(155)
|
(150)
|
(157)
|
(137)
|
(133)
|
(136)
|
(169)
|
(170)
|
(186)
|
(182)
|
(194)
|
(170)
|
(154)
|
(132)
|
(114)
|
(106)
|
(105)
|
(119)
|
(141)
|
(130)
|
(126)
|
(130)
|
(144)
|
(137)
|
(136)
|
(146)
|
(120)
|
|
Selling, General & Administrative |
(106)
|
(103)
|
(105)
|
(104)
|
(93)
|
(112)
|
(121)
|
(131)
|
(126)
|
(144)
|
(148)
|
(159)
|
(139)
|
(153)
|
(151)
|
(146)
|
(147)
|
(154)
|
(156)
|
(162)
|
(172)
|
(174)
|
(185)
|
(182)
|
(172)
|
(166)
|
(149)
|
(126)
|
(95)
|
(109)
|
(108)
|
(118)
|
(124)
|
(127)
|
(124)
|
(133)
|
(115)
|
(134)
|
(140)
|
(146)
|
(113)
|
|
Research & Development |
0
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
(2)
|
(4)
|
(4)
|
(5)
|
(4)
|
(5)
|
(10)
|
(11)
|
(11)
|
(8)
|
(11)
|
(12)
|
(17)
|
(10)
|
(13)
|
(12)
|
(8)
|
(6)
|
(8)
|
(9)
|
(8)
|
(8)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
(26)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
(18)
|
|
Other Operating Expenses |
(0)
|
(0)
|
(2)
|
(2)
|
(1)
|
(1)
|
(4)
|
(2)
|
1
|
0
|
2
|
(2)
|
3
|
(4)
|
(4)
|
(4)
|
13
|
16
|
23
|
27
|
25
|
9
|
5
|
5
|
15
|
6
|
5
|
5
|
15
|
15
|
16
|
16
|
12
|
10
|
10
|
11
|
8
|
6
|
14
|
8
|
20
|
|
Operating Income |
26
N/A
|
17
-33%
|
13
-22%
|
0
-99%
|
(4)
N/A
|
2
N/A
|
6
+263%
|
9
+50%
|
23
+161%
|
23
0%
|
24
+6%
|
29
+22%
|
37
+25%
|
40
+9%
|
44
+11%
|
40
-9%
|
56
+40%
|
61
+7%
|
65
+8%
|
71
+9%
|
72
+2%
|
61
-15%
|
59
-4%
|
70
+19%
|
73
+4%
|
67
-8%
|
82
+21%
|
76
-7%
|
72
-4%
|
66
-9%
|
95
+43%
|
184
+94%
|
227
+23%
|
270
+19%
|
262
-3%
|
180
-31%
|
164
-9%
|
139
-15%
|
102
-26%
|
100
-2%
|
78
-22%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
4
|
12
|
17
|
20
|
17
|
15
|
12
|
11
|
15
|
11
|
13
|
12
|
13
|
11
|
11
|
9
|
1
|
(1)
|
(2)
|
(4)
|
(18)
|
(11)
|
(18)
|
(20)
|
(23)
|
(17)
|
(13)
|
(14)
|
(12)
|
(11)
|
(8)
|
0
|
7
|
7
|
8
|
3
|
(5)
|
(9)
|
(12)
|
(17)
|
(14)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
1
|
(1)
|
0
|
0
|
0
|
3
|
0
|
0
|
(0)
|
(1)
|
0
|
0
|
0
|
(0)
|
|
Total Other Income |
18
|
20
|
18
|
19
|
13
|
12
|
12
|
13
|
11
|
12
|
13
|
11
|
9
|
9
|
11
|
11
|
(1)
|
(3)
|
(6)
|
(8)
|
(2)
|
(2)
|
(3)
|
(3)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(3)
|
(2)
|
(1)
|
1
|
|
Pre-Tax Income |
48
N/A
|
48
0%
|
48
0%
|
39
-20%
|
26
-32%
|
28
+8%
|
30
+5%
|
33
+10%
|
48
+46%
|
45
-5%
|
49
+9%
|
53
+6%
|
58
+11%
|
60
+2%
|
66
+10%
|
61
-7%
|
57
-7%
|
57
0%
|
58
+1%
|
59
+3%
|
53
-11%
|
48
-8%
|
38
-21%
|
48
+27%
|
46
-5%
|
50
+9%
|
67
+36%
|
61
-9%
|
60
-2%
|
54
-9%
|
86
+58%
|
183
+114%
|
237
+29%
|
276
+17%
|
269
-3%
|
182
-32%
|
157
-14%
|
127
-19%
|
88
-31%
|
81
-8%
|
65
-20%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(7)
|
(7)
|
(7)
|
(5)
|
(3)
|
(4)
|
(4)
|
(4)
|
(7)
|
(6)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(10)
|
(8)
|
(8)
|
(8)
|
(9)
|
(10)
|
(9)
|
(8)
|
(9)
|
(11)
|
(11)
|
(13)
|
(13)
|
(10)
|
(9)
|
(15)
|
(27)
|
(35)
|
(41)
|
(41)
|
(31)
|
(24)
|
(20)
|
(13)
|
(13)
|
(11)
|
|
Income from Continuing Operations |
41
|
41
|
41
|
34
|
23
|
25
|
26
|
28
|
41
|
39
|
42
|
45
|
49
|
50
|
55
|
52
|
49
|
49
|
50
|
51
|
43
|
39
|
30
|
39
|
35
|
39
|
54
|
49
|
50
|
45
|
71
|
156
|
202
|
235
|
228
|
152
|
133
|
107
|
75
|
69
|
54
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
41
N/A
|
41
+0%
|
41
+0%
|
34
-19%
|
23
-32%
|
25
+8%
|
26
+4%
|
28
+11%
|
41
+44%
|
39
-5%
|
42
+9%
|
45
+5%
|
49
+11%
|
50
+2%
|
55
+10%
|
52
-6%
|
50
-5%
|
50
+0%
|
50
+1%
|
51
+1%
|
43
-15%
|
39
-9%
|
30
-22%
|
39
+30%
|
35
-10%
|
39
+11%
|
54
+39%
|
49
-10%
|
50
+2%
|
45
-10%
|
71
+59%
|
156
+120%
|
202
+29%
|
235
+17%
|
228
-3%
|
152
-33%
|
133
-12%
|
107
-19%
|
75
-30%
|
69
-9%
|
54
-21%
|
|
EPS (Diluted) |
0.08
N/A
|
0.11
+38%
|
0.1
-9%
|
0.08
-20%
|
0.06
-25%
|
0.06
N/A
|
0.07
+17%
|
0.08
+14%
|
0.11
+38%
|
0.11
N/A
|
0.12
+9%
|
0.13
+8%
|
0.13
N/A
|
0.15
+15%
|
0.16
+7%
|
0.15
-6%
|
0.13
-13%
|
0.14
+8%
|
0.14
N/A
|
0.14
N/A
|
0.12
-14%
|
0.11
-8%
|
0.09
-18%
|
0.11
+22%
|
0.1
-9%
|
0.11
+10%
|
0.15
+36%
|
0.14
-7%
|
0.14
N/A
|
0.12
-14%
|
0.19
+58%
|
0.42
+121%
|
0.55
+31%
|
0.64
+16%
|
0.62
-3%
|
0.41
-34%
|
0.36
-12%
|
0.29
-19%
|
0.2
-31%
|
0.19
-5%
|
0.15
-21%
|